HIV

TRUVADA™

(tenofovir disoproxil fumarate/emtricitabine) 300 mg/200 mg TABLETS

WHAT IS IN THIS LEAFLET

Read all of this leaflet carefully before you start taking this medicine.

This leaflet answers some of the common questions about TRUVADA tablets. It does not contain all of the available information.

It does not take the place of talking to your doctor or pharmacist about your medical condition or treatment. If you have further questions, please ask your doctor or your pharmacist.

Trizivir™ Tablets

Lamivudine 150mg, zidovudine 300mg and abacavir (as sulphate) 300mg tablets

If you have had a hypersensitivity (allergic) reaction to
Trizivir or Ziagen, NEVER take Trizivir or Ziagen again as you may develop a
life threatening reaction which has caused death. See more details under
Side Effects.

What is in this leaflet?

Please read this leaflet carefully before you start taking Trizivir tablets

STOCRIN®

efavirenz

50 mg, 100 mg & 200 mg capsules

50 mg, 200 mg & 600 mg tablets

What is in this leaflet

This leaflet answers some common questions about STOCRIN. It does not
contain all the available information. It does not take the place of talking
to your doctor or pharmacist.

All medicines have risks and benefits. Your doctor has weighed the risks of
you taking STOCRIN against the benefits they expect it will have for you.

REYATAZ® Capsules

Atazanavir

What is in this leaflet

Read this leaflet carefully before taking Reyataz. This leaflet answers some
common questions about Reyataz.

It does not contain all the available information.

It does not take the place of talking to your doctor or pharmacist.

All medicines have risks and benefits. Your doctor has weighed the risks of
you taking Reyataz against the benefits they expect it will have for you.

If you have any concerns about taking this medicine, ask your doctor or
pharmacist.

RETROVIR™

Zidovudine capsules 100mg, oral solution 10mg/mL, IV infusion 10mg/mL

What is in this leaflet

Please read this leaflet carefully before you start taking RETROVIR capsules
or oral solution, or are given RETROVIR by IV infusion.

This leaflet answers some common questions about RETROVIR. It does not
contain all of the available information.

NORVIR®

PLEASE READ THIS INFORMATION CAREFULLY

What is in this leaflet

This leaflet answers some common questions about NORVIR.

It does not contain all of the available information. It does not take the
place of talking to your doctor or pharmacist.

All medicines have benefits and risks. Your doctor has weighed the risks of
you taking NORVIR against the benefits they expect it will have on you.

If you have any concerns about taking this medicine, talk to your doctor
or pharmacist.

Neupogen®

Filgrastim

300 mcg in 0.5mL and 480 mcg in 0.5mL (prefilled syringes) and 300 mcg in 1mL
(vials)

solution for injection

What is in this leaflet

This leaflet answers some common questions about NEUPOGEN.

It does not contain all the available information.

It does not take the place of talking to your doctor or pharmacist.

All medicines have risks and benefits. Your doctor has weighed the risks of
your taking NEUPOGEN against the benefits expected for you.

KLAMYCIN

Clarithromycin

What is in this leaflet

This leaflet answers some common questions about Klamycin. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Klamycin against the benefits expected for you. If you have concerns about using this medicine ask your doctor or pharmacist.
Keep this leaflet with your medicine. You may need to read it again.

KIVEXA™ tablets

abacavir (as sulfate) and lamivudine

Patients taking Kivexa, which contains abacavir, may develop a
hypersensitivity reaction (serious allergic reaction) which can be
life-threatening
if treatment with Kivexa is continued. CONTACT YOUR
DOCTOR IMMEDIATELY for advice on whether you should stop taking Kivexa if:

  1. you get a skin rash OR
  2. you get one or more symptoms from at least TWO of the following
    groups:

KALETRA® Tablets and KALETRA™ Oral Solution

200mg lopinavir &
50mg ritonavir per tablet

80mg lopinavir &
20mg ritonavir per mL

PLEASE READ THIS INFORMATION CAREFULLY

What is in this leaflet

This leaflet answers some common questions about Kaletra.

It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist.

All medicines have benefits and risks. Your doctor has weighed the risks of you taking Kaletra against the benefits they expect it will have on you.

this site is hosted by FOR FREE by FreeDrupal5Hosting.com